Literature DB >> 24662832

Basonuclin-1 modulates epithelial plasticity and TGF-β1-induced loss of epithelial cell integrity.

A Feuerborn1, D Mathow1, P K Srivastava2, N Gretz3, H-J Gröne1.   

Abstract

Transforming growth factor-β1 (TGF-β1) is a multifunctional cytokine and critically involved in the progression of a variety of cancers. TGF-β1 signaling can impair tumor development by its anti-proliferative and pro-apoptotic features. In contrast, it may actively promote tumor progression and cancer cell dissemination by inducing a gradual switch from epithelial towards mesenchymal-like cell features (EMT-like), including decreased intercellular adhesion. Here, we show that expression of the transcription factor Basonuclin-1 (Bnc1) modulates TGF-β1-induced epithelial dedifferentiation of mammary epithelial cells. RNAi-mediated repression of Bnc1 resulted in enhanced intercellular adhesion and strongly impaired TGF-β1-dependent sheet disintegration and cell scattering. In contrast, forced expression of Bnc1 modifies plasma membrane/cytoskeletal dynamics and seemingly interferes with the initiation of sustainable cell-cell contacts. Follow-up analyses revealed that Bnc1 affects the expression of numerous TGF-β1-responsive genes including distinct EMT-related transcription factors, some of which modulate the expression of Bnc1 themselves. These results suggest that Bnc1 is part of a transcription factor network related to epithelial plasticity with reciprocal feedback-loop connections on which Smad-factors integrate TGF-β1 signaling. Our study demonstrates that Bnc1 regulates epithelial plasticity of mammary epithelial cells and influences outcome of TGF-β1 signaling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662832     DOI: 10.1038/onc.2014.54

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Clinicopathological significance and underlying molecular mechanism of downregulation of basonuclin 1 expression in ovarian carcinoma.

Authors:  Zi-Qian Liang; Lu-Yang Zhong; Jie Li; Jin-Hai Shen; Xin-Yue Tu; Zheng-Hong Zhong; Jing-Jing Zeng; Jun-Hong Chen; Zhu-Xin Wei; Yi-Wu Dang; Su-Ning Huang; Gang Chen
Journal:  Exp Biol Med (Maywood)       Date:  2021-10-13

2.  Zeb1 affects epithelial cell adhesion by diverting glycosphingolipid metabolism.

Authors:  Daniel Mathow; Federica Chessa; Mariona Rabionet; Sylvia Kaden; Richard Jennemann; Roger Sandhoff; Hermann-Josef Gröne; Alexander Feuerborn
Journal:  EMBO Rep       Date:  2015-02-02       Impact factor: 8.807

3.  Multi-omics mapping of human papillomavirus integration sites illuminates novel cervical cancer target genes.

Authors:  Marissa Iden; Shirng-Wern Tsaih; Yi-Wen Huang; Pengyuan Liu; Meizhu Xiao; Michael J Flister; Janet S Rader
Journal:  Br J Cancer       Date:  2021-09-15       Impact factor: 9.075

4.  The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain.

Authors:  Rajendra P Pangeni; Prasanna Channathodiyil; David S Huen; Lawrence W Eagles; Balraj K Johal; Dawar Pasha; Natasa Hadjistephanou; Oliver Nevell; Claire L Davies; Ayobami I Adewumi; Hamida Khanom; Ikroop S Samra; Vanessa C Buzatto; Preethi Chandrasekaran; Thoraia Shinawi; Timothy P Dawson; Katherine M Ashton; Charles Davis; Andrew R Brodbelt; Michael D Jenkinson; Ivan Bièche; Farida Latif; John L Darling; Tracy J Warr; Mark R Morris
Journal:  Clin Epigenetics       Date:  2015-05-27       Impact factor: 6.551

5.  A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data.

Authors:  Yuanyuan Li; Kai Kang; Juno M Krahn; Nicole Croutwater; Kevin Lee; David M Umbach; Leping Li
Journal:  BMC Genomics       Date:  2017-07-03       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.